Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonello Mai

Showing results (1-10 of 359) with videos related to

Pageof 36
Sort By:
Aging|September 23, 2011
Identification of specific and semi-specific SIRT inhibitors through computer-aided studiesAntonello Mai
Chemmedchem|March 5, 2014
Targeting epigenetics in drug discoveryAntonello Mai
Epigenomics|November 30, 2011
Small-molecule chromatin-modifying agents: therapeutic applicationsAntonello Mai
Expert Opinion on Therapeutic Targets|May 17, 2007
The therapeutic uses of chromatin-modifying agentsAntonello Mai
Expert Opinion on Therapeutic Patents|January 9, 2014
Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 - 2013)Sergio Valente, Antonello Mai
The International Journal of Biochemistry & Cell Biology|September 16, 2008
Epi-drugs to fight cancer: from chemistry to cancer treatment, the road aheadAntonello Mai, Lucia Altucci
Genes & Cancer|September 24, 2011
Targeting Histone Demethylases: A New Avenue for the Fight against CancerDante Rotili, Antonello Mai
Drug Discovery Today|November 12, 2022
PD-L1 small-molecule modulators: A new hope in epigenetic-based multidrug cancer therapy?Clemens Zwergel, Rossella Fioravanti, Antonello Mai
Expert Opinion on Therapeutic Patents|July 16, 2011
Epigenetic modulation of PGC-1α activity by GCN5 inhibitors: WO2010007085Simone Carradori, Daniela Secci, Antonello Mai
Frontiers in Pharmacology|September 9, 2020
Lysine Acetyltransferase Inhibitors From Natural SourcesFrancesco Fiorentino, Antonello Mai, Dante Rotili
Pageof 36

Showing results (1-10 of 359) with videos related to

Sort By:
Pageof 36
Aging|September 23, 2011
Identification of specific and semi-specific SIRT inhibitors through computer-aided studiesAntonello Mai
Chemmedchem|March 5, 2014
Targeting epigenetics in drug discoveryAntonello Mai
Epigenomics|November 30, 2011
Small-molecule chromatin-modifying agents: therapeutic applicationsAntonello Mai
Expert Opinion on Therapeutic Targets|May 17, 2007
The therapeutic uses of chromatin-modifying agentsAntonello Mai
Expert Opinion on Therapeutic Patents|January 9, 2014
Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011 - 2013)Sergio Valente, Antonello Mai
The International Journal of Biochemistry & Cell Biology|September 16, 2008
Epi-drugs to fight cancer: from chemistry to cancer treatment, the road aheadAntonello Mai, Lucia Altucci
Genes & Cancer|September 24, 2011
Targeting Histone Demethylases: A New Avenue for the Fight against CancerDante Rotili, Antonello Mai
Drug Discovery Today|November 12, 2022
PD-L1 small-molecule modulators: A new hope in epigenetic-based multidrug cancer therapy?Clemens Zwergel, Rossella Fioravanti, Antonello Mai
Expert Opinion on Therapeutic Patents|July 16, 2011
Epigenetic modulation of PGC-1α activity by GCN5 inhibitors: WO2010007085Simone Carradori, Daniela Secci, Antonello Mai
Frontiers in Pharmacology|September 9, 2020
Lysine Acetyltransferase Inhibitors From Natural SourcesFrancesco Fiorentino, Antonello Mai, Dante Rotili
Pageof 36